{
  "id": 3775281,
  "title": "Michael Polansky has a new, skin-focused biotech. Don’t call it a drug company.",
  "url": "https://urgent.news/2026/08/27/michael-polansky-has-a-new-skin-focused-biotech-dont-call-it-a-drug",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-27T16:32:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/outer-bio-skin-biotech-michael-polansky-cosmetics-pharma/828910/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Though its data could be useful for pharmaceutical firms, Polansky’s latest entrepreneurial endeavor, Outer Bio, is serious about steering clear of road bumps that slow biotechs.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}